300086 康芝药业
交易中 06-17 14:13:27
资讯
新帖
简况
康芝药业最新公告:提请股东大会授权董事会办理以简易程序向特定对象发行股票
证券之星 · 06-07
康芝药业最新公告:提请股东大会授权董事会办理以简易程序向特定对象发行股票
康芝药业(300086)5月10日主力资金净卖出2034.37万元
证券之星 · 05-10
康芝药业(300086)5月10日主力资金净卖出2034.37万元
康芝药业(300086.SZ)发布2023年度业绩,净利润1153万元,同比扭亏为盈
智通财经 · 04-28
康芝药业(300086.SZ)发布2023年度业绩,净利润1153万元,同比扭亏为盈
康芝药业(300086.SZ)发布一季度业绩,净亏损4650万元,同比由盈转亏
智通财经 · 04-28
康芝药业(300086.SZ)发布一季度业绩,净亏损4650万元,同比由盈转亏
图解康芝药业年报:第四季度单季净利润同比增141.02%
证券之星 · 04-28
图解康芝药业年报:第四季度单季净利润同比增141.02%
国改“炒地图”行情已明牌,上海⇒海南⇒福建⇒新疆…,还能上车吗?
格隆汇 · 01-26
国改“炒地图”行情已明牌,上海⇒海南⇒福建⇒新疆…,还能上车吗?
康芝药业:目前公司药品及医疗防护用品主要为内销
财华社 · 2023-12-20
康芝药业:目前公司药品及医疗防护用品主要为内销
公司概况
公司名称:
康芝药业股份有限公司
所属行业:
医药制造业
上市日期:
2010-05-26
主营业务:
康芝药业股份有限公司的主营业务是儿童药、母婴健康用品的研发生产与销售、医疗防护用品等医疗器械。主要产品是儿童药、成人药、母婴健康用品、医疗器械。公司生产经营5种剂型11个儿童药品种,涵盖了我国当前儿童用药中销量最大的解热镇痛类、感冒类、抗生素类、呼吸系统类、消食定惊类和营养类等六大类的西药和中成药。公司现生产和销售的自有儿童药产品主要包括瑞芝清(尼美舒利颗粒)、注射用头孢米诺钠、止咳橘红颗粒(国家二级中药保护品种)、感冒清热颗粒等品种。评为“中国驰名商标”。
发行价格:
60.00
{"stockData":{"symbol":"300086","market":"SZ","secType":"STK","nameCN":"康芝药业","latestPrice":3.61,"timestamp":1718604807000,"preClose":3.69,"halted":0,"volume":2971550,"delay":0,"floatShares":436000000,"shares":450000000,"eps":-0.112,"marketStatus":"交易中","marketStatusCode":2,"change":-0.08,"latestTime":"06-17 14:13:27","open":3.68,"high":3.68,"low":3.61,"amount":10804900,"amplitude":0.019,"askPrice":3.62,"askSize":303,"bidPrice":3.61,"bidSize":1018,"shortable":0,"etf":0,"ttmEps":-0.112,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1718607600000},"adr":0,"adjPreClose":3.69,"symbolType":"stock","openAndCloseTimeList":[[1718587800000,1718595000000],[1718600400000,1718607600000]],"highLimit":4.06,"lowLimit":3.32,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":450000000,"pbRate":1.27,"roa":"--","roe":"--","epsLYR":0.0256,"committee":0.205047,"marketValue":1625000000,"floatMarketCap":1573000000,"peRate":-32.232142,"changeRate":-0.0217,"turnoverRate":0.0068,"status":1},"requestUrl":"/m/hq/s/300086/wiki","defaultTab":"wiki","newsList":[{"id":"2441577850","title":"康芝药业最新公告:提请股东大会授权董事会办理以简易程序向特定对象发行股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2441577850","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441577850?lang=zh_cn&edition=full","pubTime":"2024-06-07 20:00","pubTimestamp":1717761609,"startTime":"0","endTime":"0","summary":"康芝药业公告,公司董事会提请股东大会授权董事会决定以简易程序向特定对象发行融资总额不超过人民币三亿元且不超过最近一年末净资产百分之二十的股票,此次发行募集资金拟用于公司主营业务相关项目及补充流动资金。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060700043421.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300086","BK0048","BK0042","BK0070","BK0239"],"gpt_icon":0},{"id":"2434862828","title":"康芝药业(300086)5月10日主力资金净卖出2034.37万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434862828","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434862828?lang=zh_cn&edition=full","pubTime":"2024-05-10 15:25","pubTimestamp":1715325935,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年5月10日收盘,康芝药业报收于4.82元,下跌4.74%,换手率4.86%,成交量21.15万手,成交额1.03亿元。康芝药业主营业务:以儿童药、母婴健康用品的研发生产与销售、医疗防护用品等医疗器械生产销售为主营业务的国内领先儿童大健康企业。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051000023006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","BK0048","BK0042","300086"],"gpt_icon":0},{"id":"2430345810","title":"康芝药业(300086.SZ)发布2023年度业绩,净利润1153万元,同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2430345810","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430345810?lang=zh_cn&edition=full","pubTime":"2024-04-28 17:51","pubTimestamp":1714297865,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康芝药业(300086.SZ)披露2023年年度报告,公司2023年度实现营收7.4亿元,同比增长38.05%;归母净利润1153万元,同比扭亏为盈;扣非净利润1356万元,同比扭亏为盈;基本每股收益0.0256元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1113435.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300086"],"gpt_icon":0},{"id":"2430103144","title":"康芝药业(300086.SZ)发布一季度业绩,净亏损4650万元,同比由盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2430103144","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430103144?lang=zh_cn&edition=full","pubTime":"2024-04-28 17:47","pubTimestamp":1714297625,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康芝药业(300086.SZ)披露2024年第一季度报告,报告期公司实现营收1.05亿元,同比下降40.01%;归母净利润亏损4650万元,同比由盈转亏;扣非净利润亏损4655万元,同比由盈转亏。基本每股收益-0.1033元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1113426.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0042","BK0239","BK0048","BK0070","300086"],"gpt_icon":0},{"id":"2430803337","title":"图解康芝药业年报:第四季度单季净利润同比增141.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430803337","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430803337?lang=zh_cn&edition=full","pubTime":"2024-04-28 16:39","pubTimestamp":1714293563,"startTime":"0","endTime":"0","summary":"证券之星消息,康芝药业2023年年报显示,公司主营收入7.4亿元,同比上升38.05%;归母净利润1152.99万元,同比上升106.15%;扣非净利润1355.85万元,同比上升107.92%;其中2023年第四季度,公司单季度主营收入2.88亿元,同比上升54.28%;单季度归母净利润3198.23万元,同比上升141.02%;单季度扣非净利润3885.35万元,同比上升165.98%;负债率36.37%,财务费用2254.29万元,毛利率60.01%。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042800003953.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300086"],"gpt_icon":0},{"id":"2406781236","title":"国改“炒地图”行情已明牌,上海⇒海南⇒福建⇒新疆…,还能上车吗?","url":"https://stock-news.laohu8.com/highlight/detail?id=2406781236","media":"格隆汇","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2406781236?lang=zh_cn&edition=full","pubTime":"2024-01-26 12:53","pubTimestamp":1706244794,"startTime":"0","endTime":"0","summary":"高度很有限","market":"us","thumbnail":"https://img3.gelonghui.com/121e1-c4077de4-9faa-439f-9fb4-a2ac754b9a43.jpg?guru_height=851&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/121e1-c4077de4-9faa-439f-9fb4-a2ac754b9a43.jpg?guru_height=851&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/688617","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK0096","BK0048","BK0250","BK0032","BK0042","BK0011","300300","002596","600639","BK0117","BK0277","000592","BK0012","BK0077","BK0140","BK0230","BK0184","BK0041","BK0053","BK0239","BK0095","BK0029","BK0022","BK0132","BK0231","000701","BK0020","BK0273","BK0054","BK0067","BK0070","BK0235","BK0040","BK0188","BK0028","BK0058","300086","BK0106","002941","BK0000","BK0185","BK0145","002307"],"gpt_icon":0},{"id":"2392151332","title":"康芝药业:目前公司药品及医疗防护用品主要为内销","url":"https://stock-news.laohu8.com/highlight/detail?id=2392151332","media":"财华社","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2392151332?lang=zh_cn&edition=full","pubTime":"2023-12-20 13:20","pubTimestamp":1703049650,"startTime":"0","endTime":"0","summary":"12月20日,康芝药业(300086.SZ)在互动平台表示,目前公司的药品及医疗防护用品主要为内销。未来公司将持续探索海外渠道,完善海外布局,更好地满足客户对药品及医疗器械产品的需求。","market":"us","thumbnail":"https://www.finet.hk/images/news_default.jpg","type":0,"news_type":0,"thumbnails":["https://www.finet.hk/images/news_default.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/65827f8e53243c32aa6fe219","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["BK0239","159891","BK0070","300086","BK0042","BK0048"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2010-05-26","address":"海南省海口市秀英区国家高新技术产业开发区药谷工业园药谷三路6号","stockEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":-0.1943},{"period":"3month","weight":-0.2807},{"period":"6month","weight":-0.3961},{"period":"1year","weight":-0.3881},{"period":"ytd","weight":-0.3714}],"companyName":"康芝药业股份有限公司","boardCode":"AI0027","perCapita":"11620股","boardName":"医药制造业","registeredCapital":"45000万元","compareEarnings":[{"period":"1week","weight":-0.0061},{"period":"1month","weight":-0.028},{"period":"3month","weight":-0.0072},{"period":"6month","weight":0.0306},{"period":"1year","weight":-0.0677},{"period":"ytd","weight":0.0194}],"survey":" 康芝药业股份有限公司的主营业务是儿童药、母婴健康用品的研发生产与销售、医疗防护用品等医疗器械。主要产品是儿童药、成人药、母婴健康用品、医疗器械。公司生产经营5种剂型11个儿童药品种,涵盖了我国当前儿童用药中销量最大的解热镇痛类、感冒类、抗生素类、呼吸系统类、消食定惊类和营养类等六大类的西药和中成药。公司现生产和销售的自有儿童药产品主要包括瑞芝清(尼美舒利颗粒)、注射用头孢米诺钠、止咳橘红颗粒(国家二级中药保护品种)、感冒清热颗粒等品种。评为“中国驰名商标”。","serverTime":1718604812356,"listedPrice":60,"stockholders":"37491人(较上一季度减少2.99%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.23.1","shortVersion":"4.23.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康芝药业(300086)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康芝药业(300086)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康芝药业,300086,康芝药业股票,康芝药业股票老虎,康芝药业股票老虎国际,康芝药业行情,康芝药业股票行情,康芝药业股价,康芝药业股市,康芝药业股票价格,康芝药业股票交易,康芝药业股票购买,康芝药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康芝药业(300086)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康芝药业(300086)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}